ISAP Researchers' Profiles

Thomas Freese, Ph.D.

Thomas E. Freese, Ph.D. (Clinical Psychology, California School of Professional Psychology, 1995), is currently the Director of Training for UCLA ISAP and the Principal Investigator and Director of the Pacific Southwest Addiction Technology Transfer Center (PSATTC). Dr. Freese has served as Principal Investigator on projects funded by the California Department of Alcohol and Drug Programs to train providers to implement Screening, Brief Intervention, and Referral to Treatment (SBIRT). Dr. Freese has also led several large projects that assist providers in implementing integrated treatment for co-occurring mental health and substance use disorders. He has been a featured presenter at conferences and meetings nationally and internationally on the impact and treatment of methamphetamine and opioid dependence. In addition, Dr. Freese has served as the Project Director on a number of studies including research on methamphetamine use. He has worked in the addiction field since 1983, and has developed and conducted trainings in 45 states and internationally, providing training and workshops for clinicians-in-training at the all levels.

Education and Training

• Occidental College, Los Angeles, CA, B.A., Psychology, 1987
• California School of Prof. Psychology, Los Angeles, CA, Ph.D., Clinical Pschology, 1995

Specialties

• Training/Technology Transfer
• Methamphetamine
• Adolescence
• Behavioral Treatments
• Lesbian, Gay, Bisexual, and Transgender (LGBT) Treatment

Contact Info

UCLA Integrated Substance Abuse Programs
11075 Santa Monica Blvd., Suite 100
Los Angeles, CA 90025
tfreese@mednet.ucla.edu.

Selected Publications

1. Freese, T.E., Rutkowski, B.A., Cohen, L., Lee, J.D., Rieckmann, T., Sharpe Potter, J., Smith Connery, H., & Weiss, R.  (2011).  Prescription Opioid Addiction Treatment Study: Findings and Strategies from a NIDA Clinical Trials Network Study.  Trainers Manual and PowerPoint Presentation.}
2. Rutkowski, B.A., Gallon, S., Rawson, R.A., Freese, T.E., Bruehl, A., Crèvecoeur-MacPail, D., Sugita, W., Molfenter, T., & Cotter, F.  (2010).  Improving client engagement and retention in treatment: The Los Angeles County experience.  Journal of Substance Abuse Treatment, 39, 78-86.
3. Tomás-Rosselló, J., Rawson, R.A., Zarza, M.J., Bellows, A., Busse, A., Saenz, E., Freese, T.E. Shawkey, M., Carise, D., Ali, R., & Ling, W.  (2010).  United National Office on Drugs and Crime International Network on Drug Dependence Treatment and Rehabilitation, Treatnet.  Substance Abuse, 31, 251-263.
4. Martino, A., Brigham, G.S., Higgins, C., Gallon, S., Freese, T.E., Albirght, L.M., Hulsey, E.G., Krom, L., Storti, S.A., Perl, H., Nugent, C.D., Pintello, D., & Condon, T.P.  (2010).  Partnerships and Pathways of dissemination:  the National Institute on Drug Abuse—Substance Abuse and Mental Health Services Administration Blending Initiative in the Clinical Trials Network.  Journal of Substance Abuse Treatment, 38, S31-S43.
5. Ling, W., Jacobs, P., Hillhouse, M., Hasson, A., Thomas, C., Freese, T., Sparenborg, S., McCarty, D., Weiss, R., Saxon, A., Cohen, A., Straus, M., Brigham, G., McLaughlin, P., & Tai, B.  (2010).  From research to the real world:  Buprenorphine in the decade of the Clinical Trials Network.  Journal of Substance Abuse Treatment, 38, S53-S60.
6. Freese, T.E., Bogenschutz, M., Durham, T., McNicholas, M., Rutkowski, B., Storti, S., Subramaniam, G., & Waters, P.  (2009).  Buprenorphine Treatment for Young Adults:  Findings and Strategies from a NIDA Clinical Trials Network Study.  Trainers Manual and Powerpoint Presentation.}
7. Freese, T.E., Brigham, G.S., Finnerty, B., Gresham-Morrison, K., Harrer, J.M., McCarty, D. & Storti, S.A. (2006). Short term opioid withdrawal using buprenorphine. Trainers Manual and Powerpoint presentation available at http:/www/attcnetwork.org/explore/priorityareas/science/blendingintiative/index.asp.}
8. Shoptaw, S., Reback, C.J., Peck, J.A., Yang, X., Rogheram-Fuller, E., Larkins, S., Veniegas, R.C., Freese, T.E., & Hucks-Ortiz, C.  (2005).  Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men.  Drug and Alcohol Dependence, 78, 125-34.
9. Freese, T.E., Amass, L., Brigham, G.S., Clare, G., Dixon, G., Finnerty, B., Strain, E., Martin, J., McCann, M.J., Obert, J.L., & Wesson, D. (2005). Buprenorphine Treatment: Training for Multidisciplinary Addiction Professionals. Trainers Manual and Powerpoint presentation available at http:/www/attcnetwork.org/explore/priorityareas/science/blendingintiative/index.asp.}
10. Amass, L., Ling, W., Freese, T.E., et al. (2004).  Bringing Buprenorphine-Naloxone Detoxification to Community Treatment Providers: The NIDA Clinical Trials Network Field Experience.  American Journal of Addictions, 13, S42-S66.
11. Freese, T.E., Miotto, K, Reback, CJ. (2002).  The effects and consequences of selected club drugs. Journal of Substance Abuse Treatment,  23, 151-156.
12. Reback, C. J., Cohen, A. J., Freese, T. E, & Shoptaw, S. (2002). Making collaboration work: Key components of practice/research partnerships. Journal of Drug Issues, 32(3), 837-848.
13. Shoptaw, S., Reback, C.J., & Freese, T.E. (2002).  Patient characteristics, HIV serostatus, and risk behaviors among gay and bisexual males seeking treatment for methampheramine abuse and dependence in Los Angeles.  Journal of Addictive Diseases, 21, 91-106.
14. Freese T.E., Obert, J., Dickow, A., Cohen, J., & Lord, R.H. (2000).  Methamphetamine abuse: Issues for special populations. Journal of Psychoactive Drugs, 32, 177-182.

Last updated - 03/25/2013

Top of Page